Thrombin inhibits migration of human hepatic myofibroblasts

Jennifer Gillibert-Duplantier1, Véronique Neaud, Jean-Frédéric Blanc

  • 1INSERM U889, Université Victor Segalen Bordeaux 2, 146 rue Léo Saignat, 33076 Bordeaux Cedex, France. jean.rosenbaum@gref.u-bordeaux2.fr

Insights

Thrombin, a key enzyme in liver fibrogenesis, inhibits human liver myofibroblast migration through two distinct pathways. This action, mediated by protease-activated receptor-1 (PAR-1), may regulate liver scarring.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Hepatology

Background:

  • Emerging data suggest thrombin's involvement in liver fibrogenesis.
  • The precise mechanism by which thrombin influences liver fibrosis remains unclear.
  • Understanding thrombin's role in myofibroblast behavior is crucial for deciphering fibrogenesis.

Purpose of the Study:

  • To investigate the effect of thrombin on human liver myofibroblast migration.
  • To elucidate the molecular mechanisms underlying thrombin's action on myofibroblasts.

Main Methods:

  • Assessed myofibroblast migration in response to thrombin.
  • Utilized thrombin antagonists, PAR-1 mimetic peptides, and antibodies to probe receptor involvement.
  • Investigated the roles of cyclooxygenase-2 (COX-2), prostaglandin E(2), and EP(2) receptors.
  • Examined signaling pathways including Akt-1 phosphorylation and PDGF-beta receptor activation.

Main Results:

  • Thrombin significantly inhibited both basal and PDGF-BB-induced myofibroblast migration.
  • The inhibitory effect on basal migration was dependent on thrombin's catalytic activity, PAR-1 activation, COX-2, prostaglandin E(2), and EP(2) receptor signaling.
  • Thrombin's inhibition of PDGF-BB-induced migration involved the suppression of PDGF-induced Akt-1 phosphorylation via dephosphorylation of the PDGF-beta receptor, independent of COX-2.

Conclusions:

  • Thrombin exerts dual inhibitory effects on human liver myofibroblast migration.
  • These mechanisms, involving PAR-1, COX-2/prostaglandin pathways, and PDGF receptor signaling, suggest thrombin's regulatory role in liver fibrogenesis.
  • Modulation of myofibroblast migration by thrombin may be a key factor in controlling liver scarring progression.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...